3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Myelodysplastic Syndromes
15
Hematologic Neoplasms
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Lymphoma, Non-Hodgkin
6
Neuroblastoma
5
Leukemia, Biphenotypic, Acute
5
Myeloproliferative Disorders
4
Graft vs Host Disease
4
Multiple Myeloma
3
Medulloblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia
3
Hodgkin Disease
3
Ganglioneuroblastoma
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Teratoma
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Recurrence
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Neurofibrosarcoma
1
Interventions
Rituximab
16
zanubrutinib
12
ibrutinib
9
venetoclax
8
Cyclophosphamide
8
pirtobrutinib
5
fludarabine phosphate
5
Whole-Body Irradiation
5
Sirolimus
5
Mycophenolic Acid
5
Bendamustine Hydrochloride
5
acalabrutinib
4
Peripheral Blood Stem Cell Transplantation
4
Dexamethasone
4
ixazomib
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Cyclosporine
3
Bortezomib
3
Biopsy
3
fludarabine
2
carfilzomib
2
Tacrolimus
2
Prednisone
2
Melphalan
2
Etoposide
2
Cyclosporins
2
Calcium Dobesilate
2
CT-P10
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Thiotepa
×
1 year
×
Clear all
No trials found.